| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/07/2001 | WO2001055324A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055323A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055322A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055321A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055320A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055319A8 Endocrine related nucleic acids, proteins and antibodies |
| 09/07/2001 | WO2001055318A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055316A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055315A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055314A8 Digestive system related nucleic acids, proteins and antibodies |
| 09/07/2001 | WO2001055312A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055311A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055310A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055309A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055308A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055307A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055304A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055303A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055302A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055301A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055208A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055207A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055204A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055203A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055202A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055201A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055200A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055163A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001054733A8 Nucleic acids, proteins and antibodies |
| 09/07/2001 | WO2001054473A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001032898A3 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 09/07/2001 | WO2001021761A3 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 09/07/2001 | WO2001016169A3 RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE |
| 09/07/2001 | WO2001012804A3 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 09/07/2001 | WO2000078119A3 Cardiomyocytes with enhanced proliferative potential |
| 09/07/2001 | WO2000075326A8 Suppressor of cytokine signaling (socs)-3 promoter and methods for its use |
| 09/07/2001 | WO2000050580B1 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 09/07/2001 | WO2000046384A9 Nucleic acid uptake and release vehicle |
| 09/07/2001 | WO2000002912A3 Disintegrin homologs |
| 09/07/2001 | CA2401775A1 Diagnostics and therapeutics for glaucoma |
| 09/07/2001 | CA2401716A1 Methods for promoting production of myelin by schwann cells |
| 09/07/2001 | CA2401621A1 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | CA2401613A1 Amino acids sequencing facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | CA2401607A1 Methods for selectively modulating survivin apoptosis pathways |
| 09/07/2001 | CA2401533A1 Tcf responsive element |
| 09/07/2001 | CA2401173A1 G12l, a gene associated with the thermal response |
| 09/07/2001 | CA2400679A1 Human schizophrenia gene |
| 09/07/2001 | CA2400595A1 Human schizophrenia gene |
| 09/06/2001 | US20010020011 Gene encapsulated in polymer; sustained release |
| 09/06/2001 | US20010020010 Polypeptide |
| 09/06/2001 | US20010020002 Androgen activity antagonists as therapies for anorexia, anorexia nervosa and disorders characterized by a pathologically underweight condition |
| 09/06/2001 | US20010019723 Complexing polynucleotide and polymer |
| 09/06/2001 | US20010019716 Ability to enter mammalian cells and to survive within macrophages; vaccines to prevent infection by Mycobacterium tuberculosis, diagnostic assays |
| 09/06/2001 | DE10061931A1 A new nucleic acid encoding M73791 HUMNOVGENE also known as HUMQM and human RPL10 is involved in tumor suppression and useful to diagnose and treat cancer |
| 09/06/2001 | DE10006889A1 Verwendung von Inhibitoren von Caspase-3 oder der Caspase-aktivierten Desoxyribonuclease (CAD) zur Behandlung von Herzerkrankungen Use of inhibitors of caspase-3 or caspase-activated deoxyribonuclease (CAD) for the treatment of heart disease |
| 09/05/2001 | EP1130122A2 Methods for the diagnosis of polymorphisms in the human EP1-R gene |
| 09/05/2001 | EP1130106A1 Non-squamous epithelium-specific transcription |
| 09/05/2001 | EP1130103A2 Nucleic acid from Tetrahymena coding for a trieterpenoid-cyclase, its production and use |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1129726A1 Method of administering adenovirus |
| 09/05/2001 | EP1129722A1 gM-negative EHV-mutants |
| 09/05/2001 | EP1129350A1 Methods for identifying modulators of bs69 activity |
| 09/05/2001 | EP1129217A2 Compositions and methods of disease diagnosis and therapy |
| 09/05/2001 | EP1129205A1 Transfection of male germ cells for generation of selectable transgenic stem cells |
| 09/05/2001 | EP1129204A1 Novel system for regulating transgene expression |
| 09/05/2001 | EP1129202A2 Chlamydia antigenes and corresponding dna fragments and uses thereof |
| 09/05/2001 | EP1129199A2 Cell signaling polypeptides and nucleic acids |
| 09/05/2001 | EP1129197A1 CATFIIIA CANDIDA ALBICANS tfIIIA GENE (CatfIIIA) AND THE CODED CATFIIIA PROTEIN |
| 09/05/2001 | EP1129196A2 Virulence genes and proteins, and their use |
| 09/05/2001 | EP1129191A1 Methods of diagnosing or treating neurological diseases |
| 09/05/2001 | EP1129183A2 Human glycine transporter type 2 |
| 09/05/2001 | EP1129177A1 Avipox vector coding an hiv antigen and a cytokine |
| 09/05/2001 | EP1129175A2 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 09/05/2001 | EP1129110A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 09/05/2001 | EP1129101A1 A novel g-protein coupled 7tm receptor (axor15) |
| 09/05/2001 | EP1128836A2 In utero transplantation of human mesenchymal stem cells |
| 09/05/2001 | CN1311822A Gene therapy method |
| 09/05/2001 | CN1311818A Neurotrophic factors |
| 09/05/2001 | CN1311246A New polypeptide-human FD17 and polynucleotide for coding such polypeptide |
| 09/04/2001 | US6284881 A nucleic acid molecule; diagnosis and therpy for allergies, parasitic infections, b cell neoplasia and atopic diseases |
| 09/04/2001 | US6284880 A dna molecule coding for a gene that has anti-apoptotic effects; for transfection of eukaryotic cells without toxic effects |
| 09/04/2001 | US6284879 A nucleic acid encoding a transporter protein; treatment of autoimmune disorders and improving immune responses |
| 09/04/2001 | US6284743 Method for modulating smooth muscle cell proliferation |
| 09/04/2001 | US6284742 Administering adenovirus and antibodies |
| 09/04/2001 | US6284741 Genetic engineered nucleic acid |
| 09/04/2001 | US6284740 Osteoprotegerin |
| 09/04/2001 | US6284728 Osteoprotegerin |
| 09/04/2001 | US6284540 Neuronal trophic support and cell differentiation by introducing nucleotide sequence |
| 09/04/2001 | US6284538 Oligonucleotide used for diabetes and cancer treatment |
| 09/04/2001 | US6284515 Signal recognition particle polypeptides and polynucleotides |
| 09/04/2001 | US6284504 Enzymatic polypeptide for use in gene therapy; for use as diagnostic tools in the detection of mutant synthetases |
| 09/04/2001 | US6284489 Enzymatic polypeptide for use in screening bactericides; wound healing agents; for prevention of bacterial infections |
| 09/04/2001 | US6284486 Human oncogene induced secreted protein I |
| 09/04/2001 | US6284485 Nucleic acids encoding osteoprotegerin |
| 09/04/2001 | US6284476 Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals |
| 09/04/2001 | US6284256 Bordetella bronchiseptica vaccine |
| 09/04/2001 | US6284255 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/04/2001 | US6284252 Transdominant TAT variants of the human immunodeficiency virus |
| 09/04/2001 | US6284242 Method for enhancing myoblast migration and invasion in the context of gene therapy |
| 09/04/2001 | US6284241 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |